BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
Bulios Fair Price
$12.36
41.1% upside
Current Price
$8.76
According to Bulios Fair Price, BCRX is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
BioCryst Pharmaceuticals, Inc. (BCRX) is an American biotechnology company specializing in research, development, and commercialization of therapeutic compounds for the treatment of rare and serious diseases. With a primary focus on developing drugs for rare metabolic disorders and infections, BioCryst Pharmaceuticals leads innovations in therapeutic approaches. The company is known for its advanced technologies and successful clinical trials, which strengthen investor confidence. BioCryst Pharmaceuticals, Inc. (BCRX) shares could be suitable for investors seeking opportunities in the biotechnology sector with an emphasis on drug development for rare diseases.
Sector
Healthcare
Industry
Biotechnology
CEO
Charles K. Gayer
Employees
435
Headquarters
Durham
Upcoming events
Earnings
Upcoming earnings report